#526 DIGEST – game changers in pancreatic cancer, lipid guideline updates, and GLP-1/GIP endoscopy holds
Episode Description
Join us as we review recent articles and news featured in The DIGEST, including updated lipid guidelines, GLP1 agonists holds and procedures, the newest drug in pancreatic cancer, and discontinuing thyroid supplementation. Fill your brain hole with a delicious stack of hotcakes! Featuring Drs. Nora Taranto (@norataranto), Laura Glick (@lauraglick) and Matt Watto (@doctorwatto).
Claim free CME for this episode at curbsiders.vcuhealth.org!
Episodes | Subscribe | Spotify | Swag! |Mailing List | Contact | CME!
Credits
- Written and Hosted by: Nora Taranto MD MSCE, Laura Glick MD, Matthew Watto MD, FACP
- Cover Art: Nora Taranto MD MSCE
- Reviewers: Emi Okamoto MD
- Technical Production: Pod Paste
- Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP
- Intro and pun
- Lipid Management Guidelines Overview
- Emerging Treatments in Oncology
- Press Release on a new KRAS Inhibitor for Pancreatic Cancer
- Perioperative Considerations for GLP-1 Use
- Deprescribing Levothyroxine in Older Adults
Sponsor: Panacea Financial
If you're about to make the leap into residency and feeling the financial pressure of that transition, visit PanaceaFinancial.com/curbsiders today.
Sponsor: UpToDate
for a limited time, get 10% off UpToDate packages with code CURB10. Visit store.uptodate.com to save on your annual or longer personal UpToDate subscription today.
Listen On
